Universal reference book for medicines
Name of the preparation: IMMUNORM (IMMUNORM)

Active substance: Echinacea

Type: Immunostimulating drug

Manufacturer: ratiopharm (Germany) manufactured by MERCKLE (Germany)
Composition, form of production and packaging
?
Tablets are round, biconvex, beige with brown spots (blotches).
1 tab.

Dried pressed juice from fresh herb Echinacea purpurea 100 mg

10 pieces.
- packings cellular planimetric (2) - packs cardboard.
?
The solution for oral administration is clear, brown or reddish brown, with a characteristic odor.
100 ml

Dried pressed juice from fresh herb Echinacea purpurea 75.6 ml

50 ml - bottles of dark glass (1) complete with a measuring cup - packs of cardboard.

100 ml - bottles of dark glass (1) complete with a measuring cup - packs of cardboard.

INSTRUCTION FOR THE SPECIALIST.

The product description was approved by the manufacturer for the 2004 print edition.

PHARMACHOLOGIC EFFECT

Immunostimulating preparation of plant origin.
The active components of the juice of Echinacea purpurea are the derivatives of caffeic acid (chicory acid and its esters) and polysaccharides (4-O-methyl-glucurono-arabinoxylan and arabino-rhamno-galactan), which increase the activity of nonspecific defense factors.
The drug stimulates the phagocytic activity of granulocytes and macrophages, and also causes an increase in the number of lymphocytes in the human body, thereby suppressing reproduction and contributing to the destruction of microorganisms.

Has anti-inflammatory effect.

PHARMACOKINETICS

The action of the herb juice of Echinacea purpurea is the cumulative effect of its components, therefore it is not possible to carry out pharmacokinetic studies.

INDICATIONS

- prevention and treatment of recurrent infectious diseases of the respiratory tract;

- prevention and treatment of recurrent infectious diseases of the urinary tract.

DOSING MODE

Adults and children over 12 years of age Immunorm appoint a dose of 100 mg (1 tab.) Or 2.5 ml of the solution for oral administration 3 times / day.
The duration of the course is no more than 8 weeks.
The time of taking the drug does not depend on the time of eating.

Before use, the solution should be diluted in a sufficient amount of liquid (water, juice).

To accurately dispense the solution, you must use the supplied measuring cup.
Tablets can be sucked, chewed, or washed with water.
SIDE EFFECT

Allergic reactions: skin rash, itching;
rarely - swelling of the face, shortness of breath.
Other: increased sweating.

CONTRAINDICATIONS

- tuberculosis;

- collagenoses;

- multiple sclerosis;

- HIV infection;

- autoimmune diseases;

- malignant neoplasms of lymphoid and hematopoietic tissue;

- Pregnancy;

- lactation (breastfeeding);

- Hypersensitivity to the components of the drug.

PREGNANCY AND LACTATION

The drug Immunorm is contraindicated for use in pregnancy and lactation.

SPECIAL INSTRUCTIONS

It is necessary to have constant medical supervision in case of recurrent infectious diseases of the respiratory tract, accompanied by prolonged retention of complaints: shortness of breath, hyperthermia, discharge of purulent or bloody sputum.

It is necessary to have medical control in case of repeated appearance of complaints from the urinary tract during the ongoing therapy with Immunorm.
Do not use other immunostimulating drugs during the period of Immunorm administration.
Do not prescribe Immunorm in the form of a solution for oral administration to patients with impaired liver function and patients with chronic alcoholism.

Caution is prescribed Immunorm in the form of tablets to patients with congenital intolerance to fructose.

Patients should be warned that in the event of side effects, Immunorm should be discontinued and the doctor should be consulted.

The drug is not addictive.

The appearance of cloudiness or flocculent sediment in the solution does not have a noticeable effect on the effectiveness of the preparation.

Use in Pediatrics

Clinical data on the effectiveness and safety of Immunorm in children under the age of 12 years are absent, and therefore the use of the drug in this category of patients is contraindicated.

OVERDOSE

To date, there have been no reports of an overdose of Immunorm.

DRUG INTERACTION

Clinically significant interaction of the Immunorm with other drugs has not been established.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

It is recommended to store the tablets at room temperature.
Shelf life - 2 years.
The solution should be stored in a dark place in a tightly closed bottle at a temperature of no higher than 25 ° C.
After opening the vial, the solution can be used for 4 weeks. Shelf life - 5 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!